🧬 SinoBioData Academic Portal
Open AccessDOI: 10.3724/abbs.2024224Original Research

CARF regulates the alternative splicing and piwi/piRNA complexes during mouse spermatogenesis through PABPC1

🇨🇳 Original Chinese Title: CARF regulates the alternative splicing and piwi/piRNA complexes during mouse spermatogenesis through PABPC1

Yuming Cao¹,Shengnan Wang¹,Jie Liu¹,Jinfeng Xu¹,Yan Liang¹,Fei Ao¹,Zexiao Wei¹,Li Wang¹

Department of Obstetrics and Gynecology, Perinatal Medical Center, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, China

Read Executive PreviewQuick FAQ
CARF regulates the alternative splicing and piwi/piRNA complexes during mouse spermatogenesis through PABPC1
Graphical Abstract / Figure
Published In
Acta Biochimica et Biophysica Sinica
Published:2024Edition:Vol. 57, Issue 4 • pp. 656-666Citation:Yuming Cao et al. (2024), Acta Biochimica et Biophysica Sinica
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Acta Biochimica et Biophysica Sinica (生物化学与生物物理学报).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • CARF deficiency in male mice leads to impaired spermatogenesis and reduced fertility, highlighting its essential role in male reproduction. • CARF interacts with key splicing factors including PABPC1 and directly targets 356 mRNAs in spermatocytes, indicating its broad regulatory impact on alternative splicing. • Loss of CARF causes aberrant splicing patterns in its target mRNAs, which may underlie the observed spermatogenic defects. • CARF modulates PIWIL1 expression and localization via PABPC1 downregulation, affecting pachytene-piRNA ratios and potentially impacting piRNA-mediated gene silencing.
Sponsored Research Highlight

Abstract

ADP-ribosylation factor collaborator (CARF), which is also known as CDKN2AIP, was first recognized as an ADP-ribosylation factor-interacting protein that participates in the activation of the ARF-p53-p21 (WAF1) signaling pathway under different conditions, such as oxidative and oncogenic stresses. The activation of this pathway often leads to cell growth arrest and apoptosis as well as senescence. Previous studies revealed that CARF, an RNA-binding protein, is critical for maintaining stem cell pluripotency and somatic differentiation. Nevertheless, its involvement in spermatogenesis has not been well examined. In this study, we show that male mice deficient in Carf expression present impaired spermatogenesis and fertility. IP-MS and RNA-seq analyses reveal that CARF/Carf interacts with multiple key splicing factors, such as PABPC1, and directly targets 356 different types of mRNAs in spermatocytes. Carf-associated mRNAs display aberrant splicing patterns when Carf expression is deficient. In addition, our results demonstrate that PIWIL1 expression and localization are altered in the Carf-/- mouse model through the downregulation of PABPC1, which further affects the ratio of pachytene-piRNA. Our study suggests that CARF is critical for regulating alternative splicing in mammalian spermatogenesis and determining infertility in male mice.

1. Introduction

Spermatogenesis refers to the dynamic biological development that takes place in seminiferous tubules [1]. Spermatogonia can self-renew and de-different into spermatogonial stem cell to replenish the pool of stem cells [2]. Type B spermatogonia are generated from type A spermatogonia before they develop into spermatocytes through mitosis and proliferation. Round spermatids, which are the first haploid cells, are subsequently generated after primary spermatocyte division. Finally, round spermatids undergo sperm deformation to form spermatozoa [3,4]. This complicated physiological process is precisely maintained and regulated by several genes at different levels [5–8]. Alternative splicing has been well demonstrated to occur particularly in the testis [9]. However, how this process affects spermatogenesis is not well understood. RNA-binding proteins can not only regulate alternative splicing of mRNAs but also participate in their transportation and translation and play a key role in spermatogenesis [10]. In fact, accumulating evidence suggests that RNA-binding proteins may play a more important role in regulating exon inclusion and protein expression than previously thought [11].

The functions of many RNA-binding proteins have been well studied; for example, poly-A binding protein cytoplasmic 1 (PABPC1) is abundantly expressed in round spermatids before elongation, during which it regulates the expression of an alternative exome that is indispensable for the completion of sperm maturation [12,13]. Spermatogenetic downregulation of RNA-binding proteins, such as PABPC1, is known to be associated with greater befit from retroelements, especially during the elongation of spermatids [14]. Exploring the upstream and downstream proteins of PABPC1 is also the main way to analyze the process of spermatogenesis [15].

Alternatively, in the haploid phase of spermatogenesis, p-element-induced wimpy testis like 1 (PIWIL1) is known to be associated with maintaining normal sperm development in the translational regulation of post-meiotic mRNAs [16]. PIWIL1 binds to PABPC1 and collectively regulates spermatogenesis [17]. If the expression and function of any of these proteins are affected, it can lead to development abnormalities and cause spermatogenesis disorders [18,19].

Many epigenetic mechanisms, including alternative splicing, which is among the most important, have been proposed to regulate transcription activity. After alternative splicing, a single gene can be transcribed into a variety of mRNA and protein isoforms that present different or even contradictory functional and structural characteristics [20]. A previous study indicated that during spermatogenesis, alternative pre-mRNA splicing is critical for the transcriptional regulation of gene expression and function [21]. Recent high-throughput analyses have shown that alternative splicing can occur in more than 95% of all human genes and 60% of mouse genes [22]. Several patterns of alternative splicing events have been identified, such as exon skipping (ES), intron retention (IR), alternative first exon (AFE) as well as mutually exclusive exon (MXE) [23]. Previous studies have shown that aberrant alternative splicing of genes related to reproductive development could result in impaired spermatogenesis and male infertility.

When it was first discovered, CARF was considered an alternative reading frame-interacting protein [24] and could inhibit the transcription of HDM2 as well as P53 signaling pathways [25]. Numerous studies have demonstrated the importance of CARF in spermatogenesis. For example, studies have shown that the number and quality of spermatozoa at 8 weeks of age are sig

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
Yuming Cao, Shengnan Wang, Jie Liu, Jinfeng Xu, Yan Liang, Fei Ao, Zexiao Wei, Li Wang (2026). CARF regulates the alternative splicing and piwi/piRNA complexes during mouse spermatogenesis through PABPC1. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2024224
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is the role of CARF in spermatogenesis?

CARF is critical for regulating alternative splicing during mammalian spermatogenesis. Deficiency of CARF in male mice leads to impaired spermatogenesis and reduced fertility, likely due to aberrant splicing of its target mRNAs and altered piRNA pathway.

How does CARF interact with PABPC1?

CARF interacts with PABPC1, a key RNA-binding protein, as revealed by IP-MS. This interaction is important for regulating alternative splicing and the expression/localization of PIWIL1, which in turn affects pachytene-piRNA ratios.

What are the downstream effects of CARF deficiency?

CARF deficiency results in aberrant splicing patterns in its target mRNAs, downregulation of PABPC1, altered PIWIL1 expression and localization, and changes in pachytene-piRNA ratios, collectively contributing to spermatogenic defects and male infertility.

What methods were used in this study?

The study used IP-MS and RNA-seq analyses to identify CARF-interacting proteins and target mRNAs, and a Carf knockout mouse model to assess spermatogenesis and fertility.

What is the significance of this study for male infertility?

This study identifies CARF as a novel regulator of spermatogenesis, providing insights into the molecular mechanisms underlying male infertility and potential targets for diagnosis or therapy.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF